What are the drug quality problems in China in recent 10 years?

1, Qi Eryao incident: In May 2006, Qiqihar No.2 Pharmaceutical Co., Ltd. used diethylene glycol instead of propylene glycol to produce armillarisin A injection, resulting in the death of 8 provinces 1 1 patients.

2. Clindamycin Phosphate Glucose Injection Event: In August 2006, Anhui Huayuan Biopharmaceutical Co., Ltd. produced illegally, and the sterility test and pyrogen test did not meet the requirements. (According to the approved process, the drug should be sterilized at 105℃ for 30 minutes. However, Anhui Huayuan lowered the sterilization temperature to 100℃ and shortened the sterilization time to 1 to 4 minutes without authorization, which obviously violated the regulations. Bacteria grew after the sample was cultured), which caused more than 80 people to have chest tightness, palpitation, kidney pain, diarrhea, nausea, vomiting, anaphylactic shock, liver and kidney function damage and other clinical symptoms, and 6 people died.

3. Inferior rabies vaccine incident: During the period from July 2008 to June 5438+ 10, the quality of seven batches of rabies vaccines for human use produced by Hebei Fuer Biopharmaceutical Co., Ltd. and Jiangsu Shen Yan Biotechnology Co., Ltd. was problematic.

4. Everyone knows the event of chromium exceeding the standard capsule.

Fake and inferior drugs occur every year, all of which have a great impact on drug safety in recent years.